Baramulti Suksessarana Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Baramulti Suksessarana Tbk trades at Rp4,280 (market cap 11.28T, 248.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp147 (market cap 576.7B, 2.63M 24h volume). The key difference: Baramulti Suksessarana Tbk is far larger — about 19.6× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (2.63M versus 248.1K). Which is the better fit depends on your goals.
| BSSR | LABS | |
|---|---|---|
Market Cap | 11.28T | 576.7B |
Volume | 248.1K | 2.63M |
Lot | 2.48K | 26.33K |
Turnover | 1.07B | 397.92M |
Average Price | 4,309.85 | 151.11 |
Value | 1.07B | 397.92M |
Indicative Equilibrium Price | 4,310 | 147 |
Indicative Equilibrium Volume | 9.4K | 311 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Baramulti Suksessarana (the "Company") was established in the Republic of Indonesia on October 31, 1990 based on the Notarial Deed no.68 of H.A Kadir Usman, S.H.The Company's Articles of Association have been amended several times, the most recent amendment of which was covered by Notarial Deed no.16 of Dirhamdan, S.H., dated December 29, 2011, regarding the increase in authorized share capital and issued and fully paid share capital.
Read more on BSSR →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →